Tower Research Capital LLC (Trc) Verrica Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,050 shares of VRCA stock, worth $48,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,050

Previous 4,690 29.0%

Holding current value

$48,097

Previous $34,000 41.18%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.95 - $7.95 $10,812 - $10,812	1,360 Added 29.0%	6,050 $48,000
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.56 $18,630 - $30,238	3,163 Added 207.14%	4,690 $34,000
Q1 2024 May 15, 2024	SELL	$4.74 - $6.81 $2,450 - $3,520	-517 Reduced 25.29%	1,527 $9,000
Q4 2023 Feb 13, 2024	SELL	$2.93 - $7.32 $5,180 - $12,941	-1,768 Reduced 46.38%	2,044 $14,000
Q3 2023 Nov 14, 2023	BUY	$3.75 - $7.46 $8,610 - $17,128	2,296 Added 151.45%	3,812 $14,000
Q2 2023 Aug 14, 2023	SELL	$5.32 - $6.79 $34,314 - $43,795	-6,450 Reduced 80.97%	1,516 $8,000
Q1 2023 May 09, 2023	BUY	$2.88 - $8.51 $4,631 - $13,684	1,608 Added 25.29%	7,966 $51,000
Q4 2022 Feb 10, 2023	SELL	$2.09 - $3.39 $1,435 - $2,328	-687 Reduced 9.75%	6,358 $18,000
Q3 2022 Nov 10, 2022	BUY	$2.17 - $4.3 $1,100 - $2,180	507 Added 7.75%	7,045 $21,000
Q2 2022 Aug 15, 2022	SELL	$1.81 - $8.93 $23,928 - $118,054	-13,220 Reduced 66.91%	6,538 $12,000
Q1 2022 May 12, 2022	BUY	$7.59 - $9.49 $30,276 - $37,855	3,989 Added 25.3%	19,758 $160,000
Q4 2021 Feb 14, 2022	BUY	$9.1 - $13.36 $136,463 - $200,346	14,996 Added 1939.97%	15,769 $144,000
Q3 2021 Nov 15, 2021	SELL	$9.55 - $13.96 $15,184 - $22,196	-1,590 Reduced 67.29%	773 $10,000
Q2 2021 Aug 16, 2021	SELL	$9.77 - $15.33 $9,007 - $14,134	-922 Reduced 28.07%	2,363 $27,000
Q1 2021 May 17, 2021	SELL	$10.51 - $17.46 $16,122 - $26,783	-1,534 Reduced 31.83%	3,285 $50,000
Q4 2020 Feb 16, 2021	SELL	$7.41 - $12.63 $83,977 - $143,135	-11,333 Reduced 70.16%	4,819 $56,000
Q3 2020 Nov 16, 2020	BUY	$6.16 - $10.3 $83,067 - $138,895	13,485 Added 505.62%	16,152 $125,000
Q2 2020 Aug 13, 2020	BUY	$9.02 - $15.12 $24,056 - $40,325	2,667 New	2,667 $29,000
Q1 2020 May 15, 2020	SELL	$7.14 - $16.86 $1,827 - $4,316	-256 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$13.08 - $17.43 $1,883 - $2,509	-144 Reduced 36.0%	256 $4,000
Q3 2019 Nov 05, 2019	BUY	$8.65 - $14.81 $3,460 - $5,924	400 New	400 $6,000
Q2 2019 Aug 13, 2019	SELL	$7.1 - $11.62 $1,789 - $2,928	-252 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$7.95 - $14.07 $5,421 - $9,595	-682 Reduced 73.02%	252 $3,000
Q4 2018 Feb 14, 2019	SELL	$6.75 - $16.12 $11,191 - $26,726	-1,658 Reduced 63.97%	934 $8,000
Q3 2018 Nov 13, 2018	BUY	$13.94 - $19.88 $36,132 - $51,528	2,592 New	2,592 $42,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Verrica Pharmaceuticals Inc. Transaction History